Vercirnon
目录号: A21315
CCR9 拮抗剂
Vercirnon(GSK-1605786)是一种口服生物利用度高的、选择性的、强效的CCR9拮抗剂,IC50为10 nM,用于炎症性肠病的研究。
Discription | Vercirnon (GSK-1605786) is an orally bioavailable, selective, and potent antagonist of CCR9, with an IC50 of 10 nM, used in the research of inflammatory bowel diseases. | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A21315 |
---|---|
分子式 | C22H21ClN2O4S |
分子量 | 444.93 |
CAS号 | 698394-73-9 |
SMILES | O=S(C1=CC=C(C(C)(C)C)C=C1)(NC2=CC=C(Cl)C=C2C(C3=CC=[N+]([O-])C=C3)=O)=O |
其他名称 | GSK-1605786; CCX282-B; Traficet-EN |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2